Last deal

$250K

Amount

Venture - Series Unknown

Stage

23.06.2014

Date

3

all rounds

$15.39M

Total amount

date founded

Financing round

General

About Company
Biomimedica pioneers new approaches to joint repair through synthetic cartilage technology.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The California-based medical device company, founded in 2007, offers a proprietary material that restores the surface of damaged joints. Using synthetic cartilage technology, Biomimedica provides innovative solutions for joint repair. Their medical devices are designed to repair joints in a way that mimics natural cartilage, providing patients with a long-lasting solution for joint pain and mobility issues.
Similar Companies
1000
CartiHeal

CartiHeal

CartiHeal is a medical device company that manufactures products for repairing articular cartilage and osteochondral defects.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Biotechnology, Medical Device

Location

Kefar Sava, Israel

total rounds

8

total raised

$41.5M
Magneto Thrombectomy

Magneto Thrombectomy

This company develops a thrombectomy device for the treatment of ischemic stroke.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device

Location

Or Yehuda, Israel

total rounds

3

total raised

$2.83M
Orteq

Orteq

Orteq is a medical device company that develops and commercializes bioengineering solutions for orthopaedic injuries.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

London, UK

total rounds

2

total raised

$14.03M

RapidPulse

RapidPulse develops minimally invasive vascular products for ischemic stroke.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Medical Device, Health Care, Biotechnology

Location

Miami, FL, USA

total rounds

2

total raised

$25.57M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$15.39M

Money Raised

Their latest funding was raised on 23.06.2014. Their latest investor Life Sciences Angel Network. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Asset Management Ventures (AMV)

Asset Management Ventures (AMV)

AMV is a venture capital firm that invests in early-stage digital health, tech, and life sciences companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Asset Management

Location

Palo Alto, CA, USA

count Of Investments

116

count Of Exists

24
Troika Dialog

Troika Dialog

Troika Dialog is a private investment bank specializing in capital markets.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Location

Moscow, Russia

count Of Investments

12

count Of Exists

1
Co-Investors
Investors
6
5

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series A, Series B, Venture - Series Unknown
Yes
Series A, Series B
Life Sciences Angel Network

Life Sciences Angel Network

Life Sciences Angel Network provides early-stage life science companies with operational, mentorship and financial support.

Sector

Investment Banking and Brokerage Services

Subsector

Investment Services

Keywords

Venture Capital, Financial Services, Life Science

Location

New York, NY, USA

count Of Investments

11

count Of Exists

3
Asset Management Ventures (AMV)

Asset Management Ventures (AMV)

AMV is a venture capital firm that invests in early-stage digital health, tech, and life sciences companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Asset Management

Location

Palo Alto, CA, USA

count Of Investments

116

count Of Exists

24
Emergent Medical Partners

Emergent Medical Partners

Emergent Medical Partners is a venture capital firm that focuses on investing in early-stage medical device and healthcare companies.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Portola Valley, CA, USA

count Of Investments

31

count Of Exists

10

People

Founders
3
Lampros Kourtis
Lampros Kourtis

Lampros Kourtis

organization founded

2

Lampros Kourtis

Eric J. Kim
Eric J. Kim

Eric J. Kim

Eric Kim was a Managing Director with Maverick Capital where he focused on the Firm’s private investments globally and led a number of investments in technology-based companies. Prior to joining Maverick, Eric co-founded Biomimedia and also worked in the US and Asia as a member of McKinsey & Company’s global strategy practice focusing on M&A, technology licensing, turnaround strategies and new product launches. Eric received his MBA from Stanford’s Graduate School of Business and his Bachelors Degree in Cognitive Science from Yale University (Magna Cum Laude), where he was elected to Phi Beta Kappa and was a recipient of the Richard U. Light Fellowship.

current job

Musical.ly
Musical.ly

Eric J. Kim

David Myung
David Myung

David Myung

Dr. David Myung, MD, PhD, is an Assistant Professor of Ophthalmology at the Byers Eye Institute at Stanford and the VA Palo Alto Health Care System, where he serves as an attending physician and cataract surgeon. He is Co-Director of the Ophthalmic Innovation Program, a project-based fellowship in the development and regulatory science of new eye care technologies, and the Director of Ophthalmologic Telemedicine. Dr. Myung leads a translational research laboratory focused on two areas of clinical need: (1) ophthalmic regenerative medicine through tissue engineering and drug delivery, and (2) global health through mobile technologies and telemedicine. His research group takes an interdisciplinary approach toward fostering regeneration of ocular tissues, by using chemistry to not only build biomimetic cellular architectures but also to target and release bioactive molecules to promote healing. Current projects are directed toward the localized delivery of growth factors and/or stem cells to wound sites, the synthesis of bioactive wound dressings and vehicles, and the creation of biopolymeric tissue scaffolds. Dr. Myung and colleagues also investigate the role of mobile technologies in enabling diagnostics and patient care outside of traditional health care settings. His goal is to challenge current paradigms of eye care delivery through new digital health technologies to increase access to care in resource-limited settings both in the US and abroad.

current job

None

organization founded

2

David Myung

Employee Profiles
4
Eric J. Kim

Eric J. Kim

Co - Founder

Daniel Chang

Daniel Chang

Consultant

Activity

Recent News
0